Acute inflammation and loss of retinal architecture and function during experimental Bacillus endophthalmitis

Current Eye Research

Volumn 31, Issue 11, 2006, Pages 955-965

  Ramadan, Raniyah T ^a   Ramirez, Raul ^b   Novosad, Billy D ^b   Callegan, Michelle C ^b,c,d  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^d NONE   (United States)

Author keywords

Bacillus; Endophthalmitis; Inflammation; Mouse; Retina

Indexed keywords

CYTOKINE; GLIAL FIBRILLARY ACIDIC PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACILLUS CEREUS; BACTERIAL GROWTH; CELL INFILTRATION; COLONY FORMING UNIT; CONTROLLED STUDY; ELECTROPHYSIOLOGY; ENDOPHTHALMITIS; EYE INFLAMMATION; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RETINA; RETINA DISEASE; RETINITIS; STRESS; VISUAL IMPAIRMENT; VITREOUS BODY;

ACUTE DISEASE; ANIMALS; BACILLACEAE INFECTIONS; BACILLUS CEREUS; DISEASE MODELS, ANIMAL; ENDOPHTHALMITIS; EYE INFECTIONS, BACTERIAL; FLOW CYTOMETRY; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; NEUTROPHILS; PEROXIDASE; RETINAL DISEASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33751187318     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.1080/02713680600976925     Document Type: Article

References (44)

1. Jett BD, Jensen HG, Atkuri RV, Gilmore MS. Evaluation of therapeutic measures for treating endophthalmitis caused by isogenic toxin-producing and toxin-nonproducing Enterococcus faecalis strains. Invest Ophthalmol Vis Sci. 1995;36:9-15.
2. Pollack JS, Beecher DJ, Pulido JS, Lee Wong AC. Failure of intravitreal dexamethasone to diminish inflammation or retinal toxicity in an experimental model of Bacillus cereus endophthalmitis. Curr Eye Res. 2004;29:253-259.
3. Engelbert M, Mino de Kaspar H, Thiel M, et al. Intravitreal vancomycin and amikacin versus intravenous imipenem in the treatment of experimental Staphylococcus aureus endophthalmitis. Graefes Arch Clin Exp Ophthalmol. 2004;242:313-320.
4. Ozkiris A, Evereklioglu C, Esel D, et al. The efficacy of intravitreal piperacillin/tazobactam in rabbits with experimental Staphylococcus epidermidis endophthalmitis: a comparison with vancomycin. Ophthalmic Res. 2005;37:168-174.
5. Ozkiris A, Evereklioglu C, Esel D, et al. The efficacy of piperacillin/tazobactam in experimental Pseudomonas aeruginosa endophthalmitis: A histopathological and microbiological evaluation. Curr Eye Res. 2005;30:13-19.
6. Yildirim O, Oz O, Aslan G, et al. The efficacy of intravitreal levofloxacin and intravitreal dexamethasone in experimental Staphylococcus epidermidis endophthalmitis. Ophthalmic Res. 2002;34:349-356.
7. Booth MC, Atkuri RV, Nanda SK, et al. Accessory gene regulator controls Staphylococcus aureus virulence in endophthalmitis. Invest Ophthalmol Vis Sci. 1995;36:1828-1836.
8. Booth MC, Cheung AL, Hatter KL, et al. Staphylococcal accessory regulator (sar) in conjunction with agr contributes to Staphylococcus aureus virulence in endophthalmitis. Infect Immun. 1997;65:1550-1556.
9. Callegan, MC, Booth MC, Jett BD, Gilmore MS. Pathogenesis of Gram-positive bacterial endophthalmitis. Infect Immun. 1999;67:3348-3356.
10. Callegan MC, Cochran DC, Kane ST, et al. Contribution of membrane-damaging toxins to Bacillus Endophthalmitis pathogenesis. Infect Immun. 2002;70:5381-5389.
11. Callegan MC, Jett BD, Hancock LE, Gilmore MS. Role of hemolysin BL in the pathogenesis of extraintestinal Bacillus cereus infection as assessed using an endophthalmitis model. Infect Immun. 1999;67:3357-3366.
12. Callegan MC, Kane ST, Cochran DC, Gilmore MS. Molecular mechanisms of Bacillus endophthalmitis pathogenesis. DNA Cell Biol. 2002;21:367-373.
13. Callegan MC, Kane ST, Cochran C, et al. Contribution of plcR-regulated toxins to Bacillus endophthalmitis pathogenesis. Infect Immun. 2003;71:3116-3124.
14. Callegan MC, Kane ST, Cochran DC, et al. Bacillus endophthalmitis: roles of bacterial toxins and motility during infection. Invest Ophthalmol Vis Sci. 2005;46:3233-3238.
15. Engelbert M, Mylonakis E, Ausubel FM, et al. Contribution of gelatinase, serine protease, and fsr to the pathogenesis of Enterococcus faecalis endophthalmitis. Infect Immun. 2004;72:3628-3633.
16. Jett BD, Atkuri RV, Gilmore MS. Enteroccus faecalis localization in experimental endophthalmitis: role of plasmid-encoded aggregation substance. Infect Immun. 1998;66:843-848.
17. Jett BD, Jensen HG, Nordquist RE, Gilmore MS. Contribution of the pAD1-encoded cytolysin to the severity of experimental Enterococcus faecalis endophthalmitis. Infect Immun. 1992;60:2445-2452.
18. Mylonakis E, Engelbert M, Qin X, et al. The Enterococcus faecalis fsrB gene, a key component of the fsr quorum-sensing system, is associated with virulence in the rabbit endophthalmitis model. Infect Immun. 2002;70:4678-4681.
19. Callegan, MC, Engelbert M, Parke DW, et al. Bacterial endophthalmitis: epidemiology, therapeutics, and bacterium-host interactions. Clin Microbiol Rev. 2002;15:111-124.
20. Engelbert M, Gilmore MS. Fas ligand but not complement is critical for control of experimental Staphlococcus aureus endophthalmitis. Invest Ophthalmol Vis Sci. 2005;46:2479-2486.
21. Jett BD, Hatter KL, Huycke MM, Gilmore MS. Simplified agar plate method for quantifying viable bacteria. BioTechniques. 1997;23:648-650.
22. Ranchon I, Gorrand JM, Cluzel J, et al. Light-induced variations of retinal sensitivity in rats. Curr Eye Res. 1998;17:14-23.
23. Sheehan DC, Hrapchak BB. Theory and Practice of Histotechnology. Columbus, OH: Batelle Press; 1987.
24. Pannicke T, Uckerman O, Iandiev I, et al. Ocular inflammation alters swelling and membrane characteristics of Muller cells. J Neuroimmunol. 2005;161:145-154.
25. Eisenfeld AJ, Bunt-Milam AH, Sarthy PV. Muller cell expression of glial fibrillary acidic protein after genetic and experimental photoreceptor degeneration in the rat retina. Invest Ophthalmol Vis Sci. 1984;25:1321-1328.
26. Sarthy V, Ripps H. The Retinal Muller Cell: Structure and Function, 1st ed. New York: Plenum Publishing; 2001.
27. Ramadan RT, Moyer AL, Hibbard AH, et al. Bacillus endophthalmitis: Retinal function loss and Muller cell dysfunction. Invest Ophthalmol Vis Sci. 2004;45:E-abstract 4015.
28. Peachey NS, Ball SL. Electrophysiological analysis of visual function in mutant mice. Documenta Ophthalmol. 2003;107:13-36.
29. Peachey NS, Fishman GA, Derlacki DJ, Brigell MG. Psychophysical and electroretinographic findings in X-linked juvenile retinoschisis. Arch Ophthalmol. 1987;105:513-516.
30. Callegan MC, Engel LS, Hill JM, O'Callaghan. Corneal virulence of Staphylococcus aureus: roles of alpha-toxin and protein A in pathogenesis. Infect Immun. 1994;62:2478-2482.
31. Hazlett LD. Pathogenic mechanisms of P. aeruginosa keratitis: a review of the role of T cells, Langerhans cells, PMN, and cytokines. DNA Cell Biol. 2002;21:383-390.
32. Hazlett LD. Role of innate and adaptive immunity in the pathogenesis of keratitis. Ocul Immunol Inflamm. 2005;13:133-138.
33. Ruan X, Chodosh J, Callegan MC, et al. Corneal expression of the inflammatory mediator CAP37. Invest Ophthalmol Vis Sci. 2002;43:1414-1421.
34. Hobden JA, Engel LS, Hill JM, et al. Prednisolone acetate or prednisolone phosphate concurrently administered with ciprofloxacin for the therapy of experimental Pseudomonas aeruginosa keratitis. Curr Eye Res. 1993;12:469-473.
35. Bennouna S, Denkers EY. Microbial antigen triggers rapid mobilization of TNF-alpha to the surface of mouse neutrophils transforming them into inducers of high-level dendritic cell TNF-alpha production. J Immunol. 2005;174:4845-4851.
36. Thomas J, Kanangat S, Rouse BT. Herpes simplex virus replication-induced expression of chemokines and proinflammatory cytokines in the eye: implications in herpetic stromal keratitis. J Interferon Cytokine Res. 1998;18:681-690.
37. Zheng M, Atherton S. Cytokine profiles and inflammatory cells during HSV-1-induced acute retinal necrosis. Invest Ophthalmol Vis Sci. 2005;46:1356-1363.
38. Luo L, Li D, Doshi A, et al. Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface. Invest Ophthalmol Vis Sci. 2004;45:4293-4301.
39. Dix RD, Cousins SW. Susceptibility to murine cytomegalovirus retinitis during progression of MAIDS: correlation with intraocular levels of tumor necrosis factor-alpha and interferon-gamma. Curr Eye Res. 2004;29:173-180.
40. Shen DF, Buggage RR, Eng HC, Chan CC. Cytokine expression in different strains of mice with endotoxin-induced uveitis (EIU). Ocul Immunol Inflamm. 2000;8:221-225.
41. Woon MD, Kaplan HJ, Bora NS. Kinetics of cytokine production in experimental autoimmune anterior uveitis (EAAU). Curr Eye Res. 1998;17:955-961.
42. Cole N, Bao S, Willcox M, Husband AJ. TNF-α production in the cornea in response to Pseudomanas aeruginosa challenge. Immunol Cell Biol. 1999;77:164-166.
43. Hazlett LD. Corneal response to Pseudomonas aeruginosa infection. Prog Retin Eye Res. 2004;23;1-30.
44. Giese MJ, Sumner HL, Berliner JA, Mondino BJ. Cytokine expression in a rat model of Staphlococcus aureus endophthalmitis. Invest Ophthalmol Vis Sci. 1998;39:2785-2790.